JnJ pledges USD 500 million investment to eliminate HIV, TB by 2030 Medical Dialogues Bureau7 Oct 2019 4:00 AM GMTNEW BRUNSWICK: Johnson & Johnson (JnJ) recently announced it has committed to ensuring more than $500 million is dedicated to world-class research...
Union Health Minister asked not to receive donations from JnJ for TB Control Program Medical Dialogues Bureau3 May 2019 3:45 AM GMTRecently, Johnson & Johnson (JnJ) had announced to provide an additional 10,000 courses of tuberculosis drug bedaquiline (BDQ) to the Indian...
Mylan, TB Alliance to commercialize Pretomanid to treat TB Farhat Nasim23 April 2019 4:30 AM GMTTB Alliance began preclinical development of pretomanid in 2002, and it has since studied pretomanid in 20 clinical trials alone or in combination...
Government must have compulsive licensing for essential drugs : Chairman, Cipla Farhat Nasim8 March 2019 4:00 AM GMTCipla Chairman, Y K Hamied said that many drugs which are not covered under patent should be made in India which is not happening at present, citing...
Cutting TB drugs prices in India: Johnson and Johnson, Mylan propose ways Ruby Khatun Khatun18 March 2018 10:21 AM GMTNew Delhi: To provide their Multidrug-Resistant (MDR) TB drugs at cheaper rates to TB patients in India so that patients could easily access to them...
